ConductScience.org, home
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer
API referenceFor AI assistants

Trial · NCT02898207

Participant flow108

How many started, completed or left each group, period by period.

81 to 100 of 108

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Dose Level 2aCOMPLETEDDose Level 2: Olaparib 300 mg and Onalespib 40 mg/m^20
Dose Level 2aCOMPLETEDDose Level 3: Olaparib 300 mg and Onalespib 80 mg/m^20
Dose Level 2aCOMPLETEDDose Level 2a: Olaparib 200 mg and Onalespib 80 mg/m^23
Dose Level 2aCOMPLETEDDose Level 3a: Olaparib 200 mg and Onalespib 120 mg/m^20
Dose Level 2aNOT COMPLETEDDose Level 0: Olaparib 200 mg and Onalespib 20 mg/m^20
Dose Level 2aNOT COMPLETEDDose Level 1: Olaparib 200 mg and Onalespib 40 mg/m^20
Dose Level 2aNOT COMPLETEDDose Level 2: Olaparib 300 mg and Onalespib 40 mg/m^20
Dose Level 2aNOT COMPLETEDDose Level 3: Olaparib 300 mg and Onalespib 80 mg/m^20
Dose Level 2aNOT COMPLETEDDose Level 2a: Olaparib 200 mg and Onalespib 80 mg/m^20
Dose Level 2aNOT COMPLETEDDose Level 3a: Olaparib 200 mg and Onalespib 120 mg/m^20
Dose Level 3aSTARTEDDose Level 0: Olaparib 200 mg and Onalespib 20 mg/m^20
Dose Level 3aSTARTEDDose Level 1: Olaparib 200 mg and Onalespib 40 mg/m^20
Dose Level 3aSTARTEDDose Level 2: Olaparib 300 mg and Onalespib 40 mg/m^20
Dose Level 3aSTARTEDDose Level 3: Olaparib 300 mg and Onalespib 80 mg/m^20
Dose Level 3aSTARTEDDose Level 2a: Olaparib 200 mg and Onalespib 80 mg/m^20
Dose Level 3aSTARTEDDose Level 3a: Olaparib 200 mg and Onalespib 120 mg/m^25
Dose Level 3aCOMPLETEDDose Level 0: Olaparib 200 mg and Onalespib 20 mg/m^20
Dose Level 3aCOMPLETEDDose Level 1: Olaparib 200 mg and Onalespib 40 mg/m^20
Dose Level 3aCOMPLETEDDose Level 2: Olaparib 300 mg and Onalespib 40 mg/m^20
Dose Level 3aCOMPLETEDDose Level 3: Olaparib 300 mg and Onalespib 80 mg/m^20

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02898207/flow?page=5

API referenceFor AI assistants